How effective are the usual treatments for ulcerative colitis?
- PMID: 15233693
- DOI: 10.1111/j.1365-2036.2004.02018.x
How effective are the usual treatments for ulcerative colitis?
Abstract
Background: Details of the efficacy of the drugs used in ulcerative colitis are not readily available.
Methods: We have reviewed all placebo-controlled trials of the commonly used drugs for both induction and maintenance of remission to determine the efficacy and to calculate the numbers needed to treat (NNTs) to achieve a specified benefit for each drug.
Results: The drug response rates and the NNTs (with 95% CI) are tabulated for each drug.
Conclusion: Corticosteroids give a remission rate of 68% in mild or moderate disease and an NNT for remission of 2 (95% CI 1.4-5) in mild disease. Intravenous hydrocortisone gives a remission rate of 60-73%. Aminosalicylates are relatively ineffective in inducing remission with an NNT of 10 (95% CI 7-21) improving to 8 (95% CI 5-20) if the dose > or = 3 g daily. They are better at maintenance (NNT = 6; 95% CI 4-8). Intravenous ciclosporin is very effective in achieving remission in severe colitis with an NNT of 1.2 (95% CI 1-2.5). Although there is fairly good evidence that azathioprine is effective in maintaining remission and is used widely, there are no suitable placebo-controlled trials to calculate the NNT.
Similar articles
-
How effective are the usual treatments for Crohn's disease?Aliment Pharmacol Ther. 2004 Jul 15;20(2):151-9. doi: 10.1111/j.1365-2036.2004.02019.x. Aliment Pharmacol Ther. 2004. PMID: 15233694 Review.
-
[Ulcerative colitis. Acute episode].Z Gastroenterol. 2004 Sep;42(9):994-8. doi: 10.1055/s-2004-813518. Z Gastroenterol. 2004. PMID: 15455271 German. No abstract available.
-
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.Aliment Pharmacol Ther. 2008 Mar;27 Suppl 1:15-21. doi: 10.1111/j.1365-2036.2008.03606.x. Aliment Pharmacol Ther. 2008. PMID: 18307645 Review.
-
Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?Gut. 2006 Apr;55(4):437-41. doi: 10.1136/gut.2005.078055. Gut. 2006. PMID: 16531519 Free PMC article. Review.
-
The state of the art in the management of inflammatory bowel disease.Rev Gastroenterol Disord. 2003 Spring;3(2):81-92. Rev Gastroenterol Disord. 2003. PMID: 12776005 Review.
Cited by
-
Emerging drugs for the treatment of ulcerative colitis.Expert Opin Emerg Drugs. 2009 Sep;14(3):505-21. doi: 10.1517/14728210903146882. Expert Opin Emerg Drugs. 2009. PMID: 19656075 Free PMC article. Review.
-
Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel Disease.Gastroenterol Hepatol (N Y). 2006 Dec;2(12):906-913. Gastroenterol Hepatol (N Y). 2006. PMID: 28331481 Free PMC article.
-
Budesonide for the treatment of ulcerative colitis.Expert Opin Pharmacother. 2016 Aug;17(11):1549-59. doi: 10.1080/14656566.2016.1183648. Epub 2016 Jun 16. Expert Opin Pharmacother. 2016. PMID: 27157244 Free PMC article. Review.
-
Second Korean guidelines for the management of ulcerative colitis.Intest Res. 2017 Jan;15(1):7-37. doi: 10.5217/ir.2017.15.1.7. Epub 2017 Jan 31. Intest Res. 2017. PMID: 28239313 Free PMC article. Review.
-
Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?J Crohns Colitis. 2014 Jan;8(1):80-4. doi: 10.1016/j.crohns.2013.07.003. Epub 2013 Aug 12. J Crohns Colitis. 2014. PMID: 23938211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical